An online tool (https://kmplot.com/) was used to test correlations between concurrent high mRNA levels of TNFa, RhoA, JAM-A, CD9 and alpha(v)beta(3) integrin and prognosis in a cohort of breast cancer patients. The gene discussed is CD9; the disease is breast carcinoma.